DrugPatentWatch Database Preview
Drugs in Development Information for Cadazolid
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the development status for investigational drug Cadazolid?
Cadazolid is an investigational drug.
There have been 5 clinical trials for Cadazolid.
The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2013.
The most common disease conditions in clinical trials are Diarrhea, Infection, and Communicable Diseases. The leading clinical trial sponsors are Actelion and [disabled in preview].
There are three US patents protecting this investigational drug and seventy-six international patents.
Summary for Cadazolid
| US Patents | 3 |
| International Patents | 76 |
| US Patent Applications | 6 |
| WIPO Patent Applications | 4 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2013-11-01) |
| Vendors | 16 |
Recent Clinical Trials for Cadazolid
| Title | Sponsor | Phase |
|---|---|---|
| Comparison of Cadazolid Versus Vancomycin in Children With Clostridium Difficile-associated Diarrhea (CDAD) | Actelion | Phase 2/Phase 3 |
| Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea | Actelion | Phase 3 |
| Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile - Associated Diarrhea | Actelion | Phase 3 |
Clinical Trial Summary for Cadazolid
Top disease conditions for Cadazolid
Top clinical trial sponsors for Cadazolid
US Patents for Cadazolid
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Cadazolid | Start Trial | Crystalline forms of cadazolid | Start Trial | |
| Cadazolid | Start Trial | 5-hydroxymethyl-oxazolidin-2-one-derivatives and their uses as antibacterials | Actelion Pharmaceuticals Ltd. (Allschwil, CH) | Start Trial |
| Cadazolid | Start Trial | Combination therapy comprising oxazolidinone-quinolones for use in treating bacterial infections | Morphochem Aktiengesellschaft Fur Kombinatorishe Chemie (Munchen, DE) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Cadazolid
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Cadazolid | Argentina | 063788 | 2026-11-10 | Start Trial |
| Cadazolid | Argentina | 071762 | 2026-11-10 | Start Trial |
| Cadazolid | Austria | 544764 | 2026-11-10 | Start Trial |
| Cadazolid | Australia | 2007318901 | 2026-11-10 | Start Trial |
| Cadazolid | Australia | 2009245351 | 2026-11-10 | Start Trial |
| Cadazolid | Brazil | PI0718862 | 2026-11-10 | Start Trial |
| Cadazolid | Brazil | PI0911991 | 2026-11-10 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
